Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
Annemieke Cats(Oncode Institute), Richard van Hilligersberg, Donald L. van der Peet(Amsterdam UMC Location Vrije Universiteit Amsterdam), Anouk Kirsten Trip(The Netherlands Cancer Institute), Ernst Jan Spillenaar Bilgen(Radboud University Nijmegen), Karen J. Neelis, Mark I. van Berge Henegouwen(University of Namur), Djamila Boerma(St. Antonius Ziekenhuis), Tom Rozema(Radboud University Nijmegen), Albert J. ten Tije(Amphia Ziekenhuis), Aart Beeker(Spaarne Ziekenhuis), Danny Houtsma, Johanna W. van Sandick(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Cornelis J.�H. van de Velde(Leiden University Medical Center), R.J.B. Blaisse(Rijnstate Hospital), Frans Erdkamp, Harm van Tinteren(Princess Máxima Center), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Karolina Sikorska(Dutch Cancer Society), Jeroen Buijsen, Marcel Verheij(Radboud University Nijmegen), Frits van Coevorden(The Netherlands Cancer Institute), Elma Meershoek‐Klein Kranenbarg(Leiden University Medical Center), Henk Boot(The Netherlands Cancer Institute), Adelheid ME Van der Torren-Conze, Marije Slingerland(Leiden University Medical Center), Annerie Slot(Radiotherapeutisch Instituut Friesland), Jeffrey P. B. M. Braak(Leiden University), Edwin P. M. Jansen(The Netherlands Cancer Institute), Hein Putter, Maud M. Geenen(Amsterdam Public Health), Marianne Nordsmark(Aarhus University Hospital), Maarten C.C.M. Hulshof(Academic Medical Center), Nicole C.T. van Grieken(Cancer Center Amsterdam), Jetske M. Meerum Terwogt(Amsterdam Public Health), Fabienne Warmerdam(Zuyderland Medisch Centrum), Henk M.W. Verheul(Erasmus MC Cancer Institute), Dick Johan van Spronsen(Radboud University Nijmegen), Maartje Los(St. Antonius Ziekenhuis), Pehr Lind(Karolinska Institutet), Bea C. Tanis(Leiden University Medical Center), Marco B. Polée(Albert Schweitzer Hospital), Henk H. Hartgrink(Leiden University Medical Center), H A Maurits Swellengrebel(The Netherlands Cancer Institute), O. J. L. Loosveld(Amphia Ziekenhuis), Johanna MGH van Riel, Q. A. J. Eijsbouts(Spaarne Ziekenhuis), Steven Vanhoutvin
Cited by 582
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Gastric cancer
|The Lancet|2020|4.8k
Persistent epigenetic differences associated with prenatal exposure to famine in humans
|Proceedings of the National Academy of Sciences|2008|3k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k